Chan Zuckerberg Biohub acquired protein-model developer EvolutionaryScale in November 2025 and named co-founder Alex Rives its Head of Science. Founded in 2023 by former Meta AI protein-team scientists, EvolutionaryScale is incorporated as a public benefit corporation.
Biohub launches a scientific initiative that combines frontier AI with frontier biology to cure or prevent disease. Announced by Mark Zuckerberg and Priscilla Chan, the initiative brings the EvolutionaryScale team into Biohub, names Alex Rives as Head of Science, and plans to expand compute capacity to 10,000 GPUs by 2028.
Biohub, a nonprofit research organization backed by Mark Zuckerberg and Priscilla Chan, hires EvolutionaryScale’s founding team. EvolutionaryScale launched with a $142 million seed round, and terms of the arrangement are not disclosed. The hiring appears to mark the end of EvolutionaryScale as an independent AI startup.
